银屑病的长期治疗和管理

被引：41

作者：

刘晓明

栾莉

机构：

[1] 大连医科大学附属第一医院皮肤科

来源：

中国皮肤性病学杂志 | 2013年 / 27卷 / 01期

关键词：

银屑病; 治疗; 管理;

D O I：

暂无

中图分类号：

R758.63 [牛皮癣（银屑病）];

学科分类号：

100227 [皮肤病学];

摘要：

总结了现阶段银屑病治疗过程中所采用的相对适用的药物、剂量、时间等高效安全方案,强调了银屑病患者心理特质及治疗依从性的重要性,分析了长期使用某种药物或治疗手段的可行性及相关的管理措施。探讨新研制药物和治疗手段的有效性和安全性,利用药理遗传学及新的评估方法筛选合适某种药物使用的银屑病患者,达到有效治疗、经济安全的目的。展望在不远的将来成立包括疾病教育、患者自身行为管理、药物治疗、物理治疗和精神情绪疏导等一揽子方案的银屑病治疗中心。

引用

页码：1 / 4

页数：4

共 11 条

[1]

心理干预对银屑病患者负性情绪的影响 [J].

王霞 ;

辛梅 ;

刘新 .

中国卫生统计, 2011, (03) :259-260+263

[2]

Methotrexate polyglutamates as a marker of patient compliance and clinical response in psoriasis: a single-centre prospective study [J].

Woolf, R. T. ;

West, S. L. ;

Arenas-Hernandez, M. ;

Hare, N. ;

Peters van Ton, A. M. ;

Lewis, C. M. ;

Marinaki, A. M. ;

Barker, J. N. W. N. ;

Smith, C. H. .

BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 (01) :165-173

[3]

Core beliefs and psychological distress in patients with psoriasis and atopic eczema attending secondary care: the role of schemas in chronic skin disease [J].

Mizara, A. ;

Papadopoulos, L. ;

McBride, S. R. .

BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (05) :986-993

[4]

Could colorimetric method replace the individual minimal erythemal dose (MED) measurements in determining the initial dose of narrow‐band UVB treatment for psoriasis patients with skin phototype III–V?.[J].I.H. Kwon;H.H. Kwon;S.J. Na;J.I. Youn.Journal of the European Academy of Dermatology and Venereology.2012, 4

[5]

Current status and new developments in the treatment of psoriasis and psoriatic arthritis with biological agents [J].

Weger, Wolfgang .

BRITISH JOURNAL OF PHARMACOLOGY, 2010, 160 (04) :810-820

[6]

British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology [J].

Ormerod, A. D. ;

Campalani, E. ;

Goodfield, M. J. D. .

BRITISH JOURNAL OF DERMATOLOGY, 2010, 162 (05) :952-963

[7]

Monoclonal anti body-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project [J].

Carson, Kenneth R. ;

Focosi, Daniele ;

Major, Eugene O. ;

Petrini, Mario ;

Richey, Elizabeth A. ;

West, Dennis P. ;

Bennett, Charles L. .

LANCET ONCOLOGY, 2009, 10 (08) :816-824

[8]

Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphoma [J].

Imanishi, Hiroyuki ;

Okamura, Noboru ;

Yagi, Mariko ;

Noro, Yukari ;

Moriya, Yuka ;

Nakamura, Tsutomu ;

Hayakawa, Akira ;

Takeshima, Yasuhiro ;

Sakaeda, Toshiyuki ;

Matsuo, Masafumi ;

Okumura, Katsuhiko .

JOURNAL OF HUMAN GENETICS, 2007, 52 (02) :166-171

[9]

The use of topical calcineurin inhibitors in dermatology: Safety concerns.[J].Timothy G. Berger;Madeleine Duvic;Abby S. Van Voorhees;Ilona J. Frieden.Journal of the American Academy of Dermatology.2006, 5

[10]

Single‐center retrospective study of long‐term use of low‐dose acitretin (Soriatane<sup>?</sup>) for psoriasis.[J].E Lee;J Koo.Journal of Dermatological Treatment.2004, 1

← 1 2 →